| [1] |
Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends[J]. Semin Liver Dis,2000,20(1):1-16.
|
| [2] |
Hwang SJ. Hepatitis C virus infection: an overview[J]. J Clin Microbiol Immunol Infect,2001,34(4):227-234.
|
| [3] |
Scheuer PJ, Afshrafzadeh P, Sherlock S, et al. The pathology of hepatitis C[J]. Hepatology,1992,15(4):567-571.
|
| [4] |
Hwang SJ, Lee SD. Hepatic steatosis and hepatitis C: Still unhappy bedfellows[J]. J Gastroenterol Hepatol,2011,26(Suppl 1):96-101.
|
| [5] |
Tanaka A, Uegaki S, Kurihara H, et al. Hepatic steatosis as a possiblerisk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C[J]. World J Gastroenterol,2007,13(39):5180- 5187.
|
| [6] |
Moriya K, Nakagawa K, Santa T, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis[J]. Cancer Res,2001.61(11):4365-4370.
|
| [7] |
de Gottardi A, Pazienza V, Pugnale P, et al. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection[J]. Aliment Pharmacol Ther,2006,23(1):107-114.
|
| [8] |
Khan M, Jahan S, Khaliq S, et al. Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis[J]. Arch Virol,2010,155(11):1735-1753.
|
| [9] |
Moriy K, Yotsuyanagi H, Shintani Y, et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice[J]. J Gen Virol,1997,78(pt7):1527-1531.
|
| [10] |
Barba G, Harper F, Harada T, et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets[J]. Proc Natl Acad Sci USA,1997,94(4):1200-1205.
|
| [11] |
Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor[J]. Cell,1997,89(3):331-340.
|
| [12] |
Shimomura I, Bashmakov Y, Horton JD, et al. Increased levels of nuclear SREBP-1c associated with fatty livers in two mousemodels of diabetes mellitus[J]. J Biol Chem,1999,274(42):30028-30032.
|
| [13] |
Horton JD, Shah NA, Warrington JA, et al. Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes[J]. Proc Natl Acad Sci USA,2003,100(21):12027-12032.
|
| [14] |
Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver[J]. J Clin Invest,2002,109(9):1125-1131.
|
| [15] |
Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes[J]. Prog Lipid Res,2001,40(6):439-452.
|
| [16] |
Abid K, Pazienza V, de Gottardi A, et al. An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation[J]. J Hepatol,2005,42(5):744-751.
|
| [17] |
Yang M, Liu W, Pellicane C, et al. Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake[J]. J Lipid Res,2014,55(2):226-238.
|
| [18] |
Li M, Wang Q, Liu SA, et al. MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein[J]. World J Gastroenterol,2015,21(15):4517-4525.
|
| [19] |
Sandip KB, Hangeun K, Keith M, et al. Forkhead Box Transcription Factor Regulation and Lipid Accumulation by Hepatitis C Virus[J]. J Virol,2014,88(8):4195-4203.
|
| [20] |
Landry J, Sutton A, Tafrov ST, et al. The silencing protein SIR2 and its homologsare NAD-dependent protein deacetylases[J]. Proc Natl Acad Sci USA,2000,97(11):5807-5811.
|
| [21] |
Langley E, Pearson M, Faretta M, et al. Human SIR2 deacetylatesp53 and antagonizes PML/p53-induced cellular senescence[J]. EMBO J, 2002,21(10):2383-2396.
|
| [22] |
Ponugoti B, Kim DH, Xiao Z, et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism[J]. J Biol Chem,2010,285(44):33959-33970.
|
| [23] |
Li X, Zhang S, Blander G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR[J]. Mol Cell,2007,28(1):91-106.
|
| [24] |
Liu X, Qiao A, Ke Y, et al. FoxO1 represses LXRalpha-mediated transcriptional activity of SREBP-1c promoter in HepG2 cells[J]. FEBS Lett,2010,584(20):4330-4334.
|